RSS-Feed abonnieren
DOI: 10.1055/s-0037-1616214
Von Willebrand Factor Propeptide in Vascular Disorders
Publikationsverlauf
Publikationsdatum:
12. Dezember 2017 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035024/200101/lookinside/thumbnails/10-1055-s-0037-1616214-1.jpg)
Summary
Von Willebrand factor (VWF) is a multifunctional plasma protein that plays a prominent role in haemostasis. In endothelial cells, processing of its precursor pro-VWF results in the formation of two large polypeptides, mature VWF and a propeptide. These proteins are co-secreted on an equimolar basis but are cleared from the circulation at different rates. VWF levels are frequently elevated in response to vascular disorders. Similarly, propeptide levels are increased under these conditions, although primarily in fulminant vascular disease, such as thrombotic thrombocytopenic purpura and septicemia. In chronic vascular disease, e.g. diabetes or peripheral vascular disease, propeptide levels are much less elevated. The differential response of VWF and propeptide levels to vascular disease could provide a means to assess the extent and time course of endothelial cell activation. After secretion, the propeptide may play a role in modulating cellular adhesion processes. Thus, enhanced propeptide secretion seems not to be of merely diagnostic significance.
-
References
- 1 Montgomery RR, Zimmerman TS. Von Willebrand‘s antigen II: a new plasma and platelet antigen deficient in severe von Willebrand‘s disease. J Clin Invest 1978; 62: 1498-507.
- 2 McCarroll DR, Ruggeri ZM, Montgomery RR. Correlation between circulating levels of von Willebrand‘s antigen II and von Willebrand factor: discrimination between type I and type II von Willebrand‘s disease. J Lab Clin Med 1984; 103: 704-11.
- 3 Verweij CL, Diergaarde P, Hart M, Pannekoek H. Full-length von Willebrand factor (VWF) cDNA encodes a highly repetitive protein, considerably larger than mature VWF subunit. EMBO J 1986; 5: 1839-47.
- 4 Bonthron DT, Handin RI, Kaufman RJ, Wasley LC, Orr EC, Mitsock LM, Ewenstein B, Loscalzo J, Ginsberg D, Orkin SH. Structure of pre-pro von Willebrand factor and its expression in heterologous cells. Nature 1986; 324: 270-3.
- 5 Fay PJ, Kawai Y, Wagner DD, Ginsburg D, Bonthron D, Ohlsson-Wilhelm BM, Chavin SI, Abraham GN, Handin RI, Orkin SH, Montgomery RR, Marder VJ. Propolypeptide of von Willebrand factor circulates in blood and is identical to von Willebrand antigen II. Science 1986; 232: 995-8.
- 6 Mannucci PM. Von Willebrand factor, a marker of endothelial damage?. Arterioscler Thromb Vasc Biol 1998; 18: 1359-2.
- 7 Van Mourik JA, Boertjes R, Huisveld IA, Fijnvandraat K, Pajkrt D, van Genderen PJJ, Fijnheer R. Von Willebrand factor propeptide in vascular disorders: a tool to distinguish between acute and chronic endothelial cell perturbation. Blood 1999; 94: 179-85.
- 8 Rubin DB, Wiener-Kronish JP, Murray JF, Green DR, Turner J, Luce JM, Montgomery AB, Marks JD, Matthay MA. Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome. J Clin Invest 1990; 86: 474-80.
- 9 Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995; 332: 635-41.
- 10 Qizilbash N, Duffy S, Prentice CRM, Boothby M, Warlow C. Von Willebrand factor and risk of ischemic stroke. Neurology 1997; 49: 1552-6.
- 11 Rumley A, Lowe GDO, Sweetnam PM, Yarnell JWG, Ford RP. Factor VIII von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study. Brit J Haematol 1999; 105: 110-6.
- 12 Goto S, Sakai H, Goto M, Ono M, Handa S, Ruggeri ZM. Enhanced shear-induced platelet aggregation in acute myocardial infarction. Circulation 1999; 99: 608-13.
- 13 Lip GYH, Blann A. Von Willebrand factor: a marker of endothelial dysfunction in vascular disorders?. Cardiovasc Res 1997; 34: 255-65.
- 14 Vischer UM, Ingerslev J, Wollheim CB, Mestries JC, Tsakiris DA, Haefeli WE, Kruithof EKO. Acute von Willebrand factor secretion from the endothelium in vivo: assessment through plasma propeptide (VWF:AgII) levels. Thromb Haemost 1997; 77: 387-93.
- 15 Van Buul-Wortelboer M, Brinkman HJ, Reinders JH, van Aken WG, van Mourik JA. Polar secretion of von Willebrand factor by endothelial cells. Biochim Biophys Acta 1989; 1011: 129-33.
- 16 Sporn LA, Marder VJ, Wagner DD. Differing polarity of the constitutive and regulated secretory pathways for von Willebrand factor in endothelial cells. J Cell Biol 1989; 108: 1283-9.
- 17 Wagner DD, Fay PJ, Sporn LA, Sinha S, Lawrence SO, Marder VJ. Divergent fates of von Willebrand factor and its propolypeptide (von Willebrand antigen II) after secretion from endothelial cells. Proc Natl Acad Sci USA 1987; 84: 1955-9.
- 18 Sporn LA, Marder VJ, Wagner DD. Von Willebrand factor released from Weibel-Palade bodies binds more avidly to extracellular matrix than that secreted constitutively. Blood 1987; 69: 1531-4.
- 19 Etingin OR, Silverstein RL, Hajjar DP. Von Willebrand factor mediates platelet adhesion to virally infected endothelial cells. Proc Natl Acad Sci USA 1993; 90: 5153-6.
- 20 André P, Denis CV, Ware J, Saffaripour S, Hynes RO, Ruggeri ZM, Wagner DD. Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins. Blood 2000; 96: 3322-8.
- 21 Borchiellini A, Fijnvandraat K, ten Cate JW, Pajkrt D, van Deventer SJH, Pasterkamp G, Meijer-Huizinga F, Zwart-Huinink L, Voorberg J, van Mourik JA. Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans. Blood 1996; 88: 2951-8.
- 22 Blann AD, de Romeuf C, Mazurier C, McCollum CN. Circulating von Willebrand factor antigen II in atherosclerosis: a comparison with von Willebrand factor and soluble thrombomodulin. Blood Coagul Fibrinolysis 1998; 9: 261-6.
- 23 Vischer UM, Emeis JJ, Bilo HJG, Stehouwer CDA, Thomsen C, Rasmussen O, Hermansen K, Wollheim CB, Ingerslev J. VWF as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the VWF propeptide (VWF:AgII). Thromb Haemost 1998; 80: 1002-7.
- 24 Wagner DD. Cell biology of von Willebrand factor. Annu Rev Cell Biol 1990; 6: 217-46.
- 25 Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 1998; 67: 395-424.
- 26 Verwey CL, Hart M, Pannekoek H. Expression of variant von Willebrand factor (VWF) cDNA in heterologous cells: requirement of the pro-polypeptide in VWF multimer formation. EMBO J 1987; 6: 2885-90.
- 27 Wise RJ, Pittman DD, Handin RI, Kaufman RJ, Orkin SH. The propeptide of von Willebrand factor independently mediates the assembly of von Willebrand multimers. Cell 1988; 52: 229-36.
- 28 Vischer U, Wagner DD. von Willebrand factor proteolytic processing and multimerization precede the formation of Weibel-Palade bodies. Blood 1994; 83: 3536-44.
- 29 Sporn LA, Marder VJ, Wagner DD. Inducible secretion of large, biologically potent von Willebrand factor multimers. Cell 1986; 46: 185-90.
- 30 Levine JD, Harlan JM, Harker LA, Joseph ML, Counts RB. Thrombin-mediated release of factor VIII-related antigen from human umbilical vein endothelial cells in culture. Blood 1982; 60: 531-4.
- 31 Loesberg C, Gonsalves MD, Zandbergen J, Willems Ch, van Aken WG, Stel HV, van Mourik JA, de Groot PG. The effect of calcium on the secretion of factor VIII-related antigen by cultured human endothelial cells. Biochim Biophys Acta 1983; 763: 160-8.
- 32 Hamilton KK, Sims PF. Changes in cytosolic Ca2+ associated with von Willebrand factor release in human endothelial cells exposed to histamine. Study of microcarrier cell monolayers using the fluorescent probe indo-1. J Clin Invest 1987; 79: 600-8.
- 33 Birch KA, Pober JS, Zavoico GB, Means AR, Ewenstein BM. Calcium/ calmodulin transduces trhombin-stimulated secretion: studies in intact and minimally permeabilized human umbilical vein endothelial cells. J Cell Biol 1992; 118: 1501-10.
- 34 Vischer UM, Wollheim CB. Purine nucleotides induce regulated secretion of von Willebrand factor: involvement of cytosolic Ca2+ and cyclic adenosine monophosphate-dependent signalling in endothelial exocytosis. Blood 1998; 91: 118-27.
- 35 Hageman RJ, van den Eijnden-Schrauwen Y, Emeis JJ. Adenosine 3′:5′-cyclic monophosphate induces regulated secretion of tissue-type plasminogen activator and von Willebrand factor from cultured human endothelial cells. Thromb Haemost 1998; 79: 853-8.
- 36 McCarroll DR, Ruggeri ZM, Montgomery RR. The effect of DDAVP on plasma levels of von Willebrand antigen II in normal individuals and patients with von Willebrand‘s disease. Blood 1984; 63: 532-5.
- 37 De Romeuf C, Mazurier C. Comparison between von Willebrand factor (VWF) and VWF antigen II in normal individuals and patients with von Willebrand disease. Thromb Haemost 1998; 80: 37-41.
- 38 De Jong SC, Stehouwer CDA, van den Berg M, Vischer UM, Rauwerda JA, Emeis JJ. Endothelial marker proteins in hyperhomocysteinemia. Thromb Haemost 1997; 78: 1332-7.
- 39 Gill JC, Endres-Brooks J, Bauer PJ, Marks Jr WJ, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691-5.
- 40 Sodetz JM, Paulson JC, McKee PA. Carbohydrate composition and identification of blood group A, B, and H oligosaccharide structures on human factor VIII/von Willebrand factor. J Biol Chem 1979; 254: 10754-60.
- 41 Matsui T, Titani K, Mizuochi T. Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor: occurrence of blood group A,B, and H(O) structures. J Biol Chem 1992; 267: 8723-31.
- 42 Matsui T, Shimoyama T, Matsumoto M, Fujimura Y, Takemoto Y, Sako M, Hamako J, Titani K. ABO blood group antigens on human plasma von Willebrand factor after ABO-mismatched bone marrow transplantation. Blood 1999; 94: 2895-900.
- 43 Scott JP, Montgomery RR. Platelet von Willebrand‘s antigen II: active release by aggregating agents and a marker of platelet release reaction in vivo. Blood 1981; 58: 1075-80.
- 44 Nichols TC, Samama CM, Bellinger DA, Roussi J, Reddick RL, Bonneau M, Read MS, Bailliart O, Koch GG, Vaiman M, Sigman JL, Pignaud GA, Brinkhous KM, Griggs TR, Drouet L. Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: Effect on arterial thrombosis in chimeras. Proc Natl Acad Sci USA 1995; 92: 2455-9.
- 45 Fijnheer R, Frijns CJM, Korteweg J, Rommes H, Peters JH, Sixma JJ, Nieuwenhuis HK. The origin of P-selectin as a circulating plasma protein. Thromb Haemost 1997; 77: 1081-5.
- 46 Blann A, Lip GYH, Gareth Beevers D, McCollum CN. Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers. Thromb Haemost 1997; 77: 1077-80.
- 47 Turecek PL, Pichler L, Auer W, Eder G, Varadi K, Mitterer A, Mundt W, Schlokat U, Drouet LO, Roussi J, van Mourik JA, Schwarz HP. Evidence for extracellular processing of pro-VWF after infusion in animals with and without severe von Willebrand disease. Blood 1999; 94: 1637-47.
- 48 Reinders JH, de Groot PhG, Gonsalves MD, Zandbergen J, Loesberg C, van Mourik JA. Isolation of a storage and secretory organelle containing von Willebrand protein from cultured human endothelial cells. Biochim Biophys Acta 1984; 803: 361-9.
- 49 Sakai H, Goto S, Kim JY, Aoki N. Plasma concentration of von Willebrand factor in acute myocardial infarction. Thromb Haemost 2000; 84: 204-9.
- 50 Jahroudi N, Lynch DC. Endothelial cell-specific regulation of von Willebrand factor gene expression. Mol Cell Biol 1994; 14: 999-1008.
- 51 Jahroudi N, Ardekani AM, Greenberger JS. Ionizing irradiation increases transcription of the von Willebrand factor gene in endothelial cells. Blood 1996; 88: 3801-14.
- 52 Usui T, Takagi J, Saito Y. Propolypeptide of von Willebrand factor serves as a substrate for factor XIIIa and is cross-linked to laminin. J Biol Chem 1993; 268: 12311-6.
- 53 Takagi J, Aoyama T, Ueki S, Ohba H, Saito Y, Lorand L. Identification of factor XIIIa-reactive glutaminyl residues in the propolypeptide of bovine von Willebrand factor. Eur J Biochem 1995; 232: 773-7.
- 54 Takagi J, Sudo Y, Saito T, Saito Y. Beta 1 integrin-mediated adhesion of melanoma cells to the propolypetide of von Willebrand factor. Eur J Biochem 1994; 222: 861-7.
- 55 Isobe T, Hisaoka T, Shimizu A, Okuno M, Aimoto S, Takada Y, Saito Y, Takagi J. Propolypeptide of von Willebrand factor is a novel ligand for very late antigen-4 integrin. J Biol Chem 1997; 272: 8447-53.
- 56 Takahashi H, Isobe T, Horibe S, Takagi J, Yokosaki Y, Sheppard D, Saito Y. Tissue transglutaminase, coagulation factor XIII, and the pro-polypeptide of von Willebrand factor are all ligands for the integrins 9 1 and 4 1. J Biol Chem 2000; 275: 23589-95.
- 57 Taooka Y, Chen J, Yednock T, Sheppard D. The integrin 9 1 mediates adhesion to activated endothelial cells and transendothelial neutrophil migration through interaction with vascular cell adhesion molecule-1. J Cell Biol 1999; 145: 413-20.
- 58 Mayadas TN, Wagner DD. Vicinal cysteines in the prosequence play a role in von Willebrand factor multimer assembly. Proc Natl Acad Sci USA 1992; 89: 3531-5.
- 59 Takagi J, Sekiya F, Kasahara K, Inada Y, Saito Y. Inhibition of platelet-collagen interaction by propolypeptide of von Willebrand factor. J Biol Chem 1989; 264: 6017-20.
- 60 Takagi J, Kasahara K, Sekiya F, Inada Y, Saito Y. A collagen-binding glycoprotein from bovine platelets is identical to propolypeptide of von Willebrand factor. J Biol Chem 1989; 264: 10425-30.
- 61 Ido Y, Vindigni A, Chang K, Stramm L, Chance R, Heath WF, DiMarch RD, Di Cera E, Williamson JR. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science 1997; 277: 563-6.
- 62 Wagner DD, Olmsted JB, Marder VJ. Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells. J Cell Biol 1982; 95: 355-60.
- 63 Ewenstein BM, Warhol MJ, Handin RI, Pober JS. Composition of the von Willebrand factor storage organelle (Weibel-Palade body) isolated from cultured human umbilical vein endothelial cells. J Cell Biol 1987; 104: 1423-33.
- 64 Bonfanti R, Furie BC, Furie B, Wagner DD. PADGEM (GMP140) is a component of Weibel-Palade bodies of human endothelial cells. Blood 1989; 73: 1109-12.
- 65 Hattori R, Hamilton KK, Fugate RD, McEver RP, Sims PJ. Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140. J Biol Chem 1989; 264: 7768-71.
- 66 McEver RP, Beckstead JH, Moore KL, Marshall-Carlson L, Bainton DF. GMP-140, a platelet α-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin Invest 1989; 84: 92-9.
- 67 Vischer UM, Wagner DD. CD63 is a component of Weibel-Palade bodies of human endothelial cells. Blood 1993; 82: 1184-91.
- 68 Russell FD, Skepper JN, Davenport AP. Evidence using immunelectron microscopy for regulated and constitutive pathways in the transport and release of endothelin. J Cardiovasc Pharm 1998; 31: 424-30.
- 69 Utgaard JO, Jahnsen FL, Bakka A, Brandtzaeg P, Haraldsen G. Rapid secretion of prestored interleukin 8 from Weibel-Palade bodies of micro-vascular endothelial cells. J Exp Med 1998; 188: 1751-6.
- 70 Wolff B, Burns AR, Middleton J, Rot A. Endothelial cell "memory" of inflammatory stimulation: human venular endothelial cells store interleukin 8 in Weibel-Palade bodies. J Exp Med 1998; 188: 1757-62.
- 71 Schnyder-Candrian S, Borsig L, Moser R, Berger EG. Localization of a 1,3-fucosyltransferase VI in Weibel-Palade bodies of human endothelial cells. Proc Natl Acad Sci USA 2000; 97: 8369-74.
- 72 Rosnoblet C, Vischer UM, Gerard RD, Irminger JC, Halban PA, Kruithof EK. Storage of tissue-type plasminogen activator in Weibel-Palade bodies of human endothelial cells. Arterioscler Thromb Vasc Biol 1999; 19: 1796-803.
- 73 Emeis JJ, van den Eijnden-Schrauwen Y, van den Hoogen CM, de Priester W, Westmuckett A, Lupu F. An endothelial storage granule for tissue-type plasminogen activator. J Cell Biol 1997; 139: 245-56.
- 74 Van de Ven WJM, Voorberg J, Fontijn R, Pannekoek H, van den Ouwe-hand AMW, van Duijnhoven HLP, Roebroek AJM, Siezen RJ. Furin is a subtilisin-like proprotein processing enzyme in higher eukaryotes. Mol Biol Rep 1990; 14: 265-75.
- 75 Wise RJ, Barr PJ, Wong PA, Kiefer MC, Brake AJ, Kaufman RJ. Expression of a human proprotein processing enzyme: correct cleavage of the von Willebrand factor precursor at a paired basic amino acid site. Proc Natl Acad Sci USA 1990; 87: 9378-82.
- 76 Laporte S, Denault JB, D’Orleans-Juste P, Leduc R. Presence of furin mRNA in cultured bovine endothelial cells and possible involvement of furin in the processing of the endothelin precursor. J Cardiovasc Pharm 1993; 22 (Suppl. 08) S7-10.
- 77 De Leeuw HP. Small GTP-binding proteins and regulated secretion of von Willebrand factor by endothelial cells. PhD Thesis, University of Amsterdam 2000.